GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill

GW Pharma (GWPH) is allegedly working with an investment bank after several companies expressed interest in a transaction. More 

PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business

Pfizer (PFE) has announced that it will be acquiring part of AstraZeneca's (AZN) antibiotic business outside the US for $725 million. More 

7 Stocks the Smart Money Loves … Or Hates

What is the smart money buying and selling lately? A look at the newest opinions on stocks like Apple, Facebook ... and an Irish aircraft leaser? More 

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today. More 

Allergan Plc: Will the Downtrend Continue for AGN Stock?

Despite chatter of a biotech acquisition and earnings Monday morning, the options market in AGN stock suggests normal event risk next week. More 

Biogen Inc (BIIB) Tacks on $7B in Market Value on Buyout Talk

Biogen Inc (NASDAQ:BIIB) just made a huge move out of thin air Tuesday evening, spiking 9.5% to $330 as of this writing. Until the surge, BIIB stock was trading in the red in the sub-$300 range. So why the sudden interest in this biotech? Well, those pesky “people familiar with the matter” are at it again,... More 

5 Smart Stock Buyback Plays

Now that earnings announcement season is ending, stock buybacks naturally pick up. Here's a quick list of five buyback plays to consider More